Sarah Blagden
From Wikipedia, the free encyclopedia
Sarah Blagden | |
|---|---|
 Photo: Matt Martin, Captis Imagery | |
| Education | Medical Degree (MBBS), PhD (as CRUK Clinical Fellow) |
| Occupation | Professor of Experimental Oncology |
| Years active | 2015 - present |
| Organisation(s) | University of Oxford, Department of Oncology |
Sarah Blagden is a Professor of Experimental Oncology at the University of Oxford. Her laboratory research is in investigating post-transcriptional mechanisms for ovarian cancer behavior. Her clinical research is in conducting early phase trials in novel cancer therapeutics for people with advanced malignancies.[1][2][3]
Sarah Blagden was born in Aldershot, Hampshire in 1969. Her father was Brigadier Patrick Blagden, a renowned mine clearance expert. She was educated in Haslemere in Surrey, and later received a BSc in pharmacology in 1991 and a medical degree (MBBS) at Charing Cross and Westminster Medical School, University of London in 1994.[4]
In 2004, she received a PhD (as CRUK Clinical Fellow) in fruit fly genetics in the laboratory of Professor David Glover at Cambridge University.[4]
